Fludarabine-Cl
Based on 2 publication(s) in Google Scholar
Fludarabine-Cl has an inhibitory effect on RNA adenosine deaminase 1 (ADAR1) with an IC50 of 0.87 μM and can be used to prevent and/or study cancer or tumor-related diseases.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.71%
- CAS. Nr.: 2734853-80-4
- Formel: C10H11ClFN5O3
- Molecular Weight:303.68
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
-
Metabolism/Protease Compound Library
HY-L012
-
Anti-Cancer Compound Library
HY-L025
-
Heterocyclic Compound Library
HY-L138
-
Metabolic Enzyme Compound Library
HY-L146
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
High-Throughput Bioactive Compound Library
HY-L205
Publications Citing Use of MedChemExpress (MCE) Fludarabine-Cl
More
Biologische Aktivität
|
ADAR1 0.87 μM (IC50) |
Fludarabine-Cl inhibits tumor cell proliferation, and has only a weak inhibitory effect on normal RWPE1 and HEK293 cells. The IC50 for MDA-MB-23, RPMI822, HL60 and K562 is 0.383, 0.149, 0.544 and 0.609 μM[1].
Fludarabine-Cl binds to ADAR1 protein with a KD of 7.24 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Fludarabine-Cl (10-20 mg/kg, intraperitoneal injection, twice a day, for 29 days) inhibits tumor proliferation in mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR mice[1]
-
Dosage:104.9, 131.1, 163.8, 204.8, 256, 320, 400 mg/kg; twice a day; one day
-
Administration:Intraperitoneal injection (i.p.)
-
Result:Was somewhat toxic and could cause death in mice at higher doses, but no abnormality in organs.
-
Animal Model:BALB/c mice induced by Du-145[1]
-
Dosage:10, 20 mg/kg; twice a day; 29 days
-
Administration:Intraperitoneal injection (i.p.)
-
Result:Inhibited tumor growth and had no effect on mouse body weight.
Chemical Information
-
CAS. Nr. 2734853-80-4
-
Appearance Solid
-
Molecular Weight 303.68
-
Formel C10H11ClFN5O3
-
Color White to off-white
-
SMILES
NC1=C2C(N([C@]3([H])O[C@@H]([C@H]([C@H]3O)O)CCl)C=N2)=NC(F)=N1
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Cell Death Differ
Targeting ADAR1 lactylation activates innate immune and overcomes chemoresistance in ovarian cancer. [Abstract]2026 May 25. PMID: 42185630 -
Reinheit & Dokumentation
-
Data Sheet (276 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Fludarabine-Cl Related Classifications
HY-145443 Related Classifications
Powered by Bioz